Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Loren Mell, MD
University of California, San Diego
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Xijing Hospital
Xi'an, China
- University Hospital Hradec Králové
Hradec Králové, Czechia
- Tata Memorial Hospital
Pārel, Mumbai, India
- Marie Sklodowska Cancer Center
Gliwice, Poland
- King Chulalongkorn Hospital
Bangkok, Thailand
- Moores Uc San Diego Cancer Center
La Jolla, California, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Oct 2011
- Primary completion
- 1 Jun 2021
- Completion
- 1 Jan 2022
- Last update posted
- 29 Nov 2024
- Registered enrollment
- 101
- Registry id
- NCT01554397
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.